clinical research, innovative practice and IRB review: identifying and respecting boundaries.
Ryan
C M
CM
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. ryancm@upmc.edu
Swanson
D P
DP
D004334:Drug Administration Schedule; D006801:Humans; D007165:Immunosuppression Therapy / Q000639:trends; D007166:Immunosuppressive Agents / Q000592:standards / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use; D014181:Transplantation Immunology / Q000502:physiology*; D014481:United States; D014486:United States Food and Drug Administration
D007166:Immunosuppressive Agents; D016559:Tacrolimus